These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 17196048

  • 1. Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial.
    Roy Chengappa KN, Schwarzman LK, Hulihan JF, Xiang J, Rosenthal NR, Clinical Affairs Product Support Study-168 Investigators.
    J Clin Psychiatry; 2006 Nov; 67(11):1698-706. PubMed ID: 17196048
    [Abstract] [Full Text] [Related]

  • 2. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.
    Kushner SF, Khan A, Lane R, Olson WH.
    Bipolar Disord; 2006 Feb; 8(1):15-27. PubMed ID: 16411977
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [Abstract] [Full Text] [Related]

  • 4. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN.
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.
    Tohen M, Chengappa KN, Suppes T, Zarate CA, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A.
    Arch Gen Psychiatry; 2002 Jan; 59(1):62-9. PubMed ID: 11779284
    [Abstract] [Full Text] [Related]

  • 6. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
    Bowden CL, Vieta E, Ice KS, Schwartz JH, Wang PP, Versavel M.
    J Clin Psychiatry; 2010 Feb; 71(2):130-7. PubMed ID: 20122373
    [Abstract] [Full Text] [Related]

  • 7. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I.
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [Abstract] [Full Text] [Related]

  • 8. Lurasidone adjunctive with lithium or valproate for bipolar depression: A placebo-controlled trial utilizing prospective and retrospective enrolment cohorts.
    Suppes T, Kroger H, Pikalov A, Loebel A.
    J Psychiatr Res; 2016 Jul; 78():86-93. PubMed ID: 27089521
    [Abstract] [Full Text] [Related]

  • 9. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study.
    Calabrese JR, Ketter TA, Youakim JM, Tiller JM, Yang R, Frye MA.
    J Clin Psychiatry; 2010 Oct; 71(10):1363-70. PubMed ID: 20673554
    [Abstract] [Full Text] [Related]

  • 10. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study.
    McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH.
    Bipolar Disord; 2002 Jun; 4(3):207-13. PubMed ID: 12180276
    [Abstract] [Full Text] [Related]

  • 11. Topiramate as add-on treatment for patients with bipolar mania.
    Chengappa KN, Rathore D, Levine J, Atzert R, Solai L, Parepally H, Levin H, Moffa N, Delaney J, Brar JS.
    Bipolar Disord; 1999 Sep; 1(1):42-53. PubMed ID: 11256656
    [Abstract] [Full Text] [Related]

  • 12. A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.
    Roy Chengappa K, Kupfer DJ, Parepally H, John V, Basu R, Buttenfield J, Schlicht P, Houck P, Brar JS, Gershon S.
    Bipolar Disord; 2007 Sep; 9(6):609-17. PubMed ID: 17845276
    [Abstract] [Full Text] [Related]

  • 13. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
    Eden Evins A, Demopulos C, Nierenberg A, Culhane MA, Eisner L, Sachs G.
    Bipolar Disord; 2006 Feb; 8(1):75-80. PubMed ID: 16411983
    [Abstract] [Full Text] [Related]

  • 14. A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.
    Sharpley AL, Williams C, Holder AA, Godlewska BR, Singh N, Shanyinde M, MacDonald O, Cowen PJ.
    Psychopharmacology (Berl); 2020 Dec; 237(12):3773-3782. PubMed ID: 32909076
    [Abstract] [Full Text] [Related]

  • 15. Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design.
    Grunze HC, Normann C, Langosch J, Schaefer M, Amann B, Sterr A, Schloesser S, Kleindienst N, Walden J.
    J Clin Psychiatry; 2001 Jun; 62(6):464-8. PubMed ID: 11465524
    [Abstract] [Full Text] [Related]

  • 16. Adjunctive topiramate in bipolar II disorder.
    Vieta E, Sánchez-Moreno J, Goikolea JM, Torrent C, Benabarre A, Colom F, Martínez-Arán A, Reinares M, Comes M, Corbella B.
    World J Biol Psychiatry; 2003 Oct; 4(4):172-6. PubMed ID: 14608588
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
    Marcus R, Khan A, Rollin L, Morris B, Timko K, Carson W, Sanchez R.
    Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
    [Abstract] [Full Text] [Related]

  • 18. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group.
    Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G.
    Bipolar Disord; 2000 Sep; 2(3 Pt 2):249-55. PubMed ID: 11249802
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H, Takita Y, Tohen M, Higuchi T, Kanba S, Takahashi M.
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [Abstract] [Full Text] [Related]

  • 20. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS, Konarski JZ, Jones M, Paulsson B.
    J Affect Disord; 2007 May; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.